|
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
Company to Focus on Small Molecule Selective Translation Regulators for Cancer
San Diego - CA, 20 May 2013
-
top
GenSight Biologics Raises €32m in a Series A Financing for Ophthalmic Gene Therapy
Paris, France, 08 April 2013
top
Avedro Completes $43 Million Series D Financing
WALTHAM, Mass, 05 March 2013
top
Gynesonics Completes $21 Million Series D Financing
Financing Validates the Attractiveness of VizAblate®
REDWOOD CITY, Calif, 22 February 2013
top
Roche and Chiasma announce collaboration to develop and commercialize Chiasma’s Octreolin® for acromegaly and neuroendocrine tumors
Jerusalem, Israel, 18 February 2013
top
U.S. FDA Approval of Aorfix™
London, UK,, 15 February 2013
top
Avillion LLP receives initial funding from
Abingworth and Clarus
London, UK, 28 January 2013
top
Labcyte Inc. Closes $5.3 Million Financing
Sunnyvale, CA, 08 January 2013
top
|